Comments

Regeneron Pharmaceuticals

Q: What sector and industry does Regeneron Pharmaceuticals (REGN) operate in?

Regeneron Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

REGNNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$714.47

-0.66-0.09%

At close: -

$714.47

0.000.00%

After Hours: 1:00 PM EDT

Regeneron Pharmaceuticals (REGN) Forecast

News Earnings Regeneron Pharmaceuticals (REGN) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Overview Rating

Speculative

Technicals Analysis

0100

Financials Analysis

0100

Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Quotes, Forecast and News Summary

Regeneron Pharmaceuticals Stock (NASDAQ: REGN) stock price, news, charts, stock research, profile.

Open	$712.30
Close	$714.47
Volume / Avg.	382.15K / 850.80K
Day Range	$706.15 - $720.00
52 Wk Range	693.00 - 1.21K
Market Cap	$78.51B
P/E Ratio	17.69
Dividend Yield	-
Exchange	NASDAQ
RSI	29
Short Interest	1.73%
Days to Cover	2.21

Recent News

Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More

JP Morgan highlights 2025 growth prospects for biopharma, animal health, and specialty pharma stocks. Key picks include Eli Lilly, Zoetis, and Bristol-Myers Squibb.

Vandana Singh

Regeneron's Best-Selling Eye Drug Eylea's Higher Dose Formulation Meets Primary Goal In Another Form Of Retinal Disease Study

Regeneron's EYLEA HD met key goals in the Phase 3 QUASAR trial for macular edema after retinal vein occlusion, with FDA submission expected in Q1 2025.

Vandana Singh

Stocks Slip As Strong November Retail Sales Raise Concerns Over 2025 Fed Rate Cuts

Wall Street began Tuesday’s session on a weaker note, with major indices slipping after November's robust retail sales report reignited investor concerns that the Federal Reserve might hold back interest rat

Piero Cingari

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug

Sep

Oct

Nov

Dec

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$712.30
Close	$714.47
Volume / Avg.	382.15K / 850.80K
Day Range	$706.15 - $720.00
52 Wk Range	693.00 - 1.21K
Market Cap	$78.51B
P/E Ratio	17.69
Dividend Yield	-
Exchange	NASDAQ
RSI	29
Short Interest	1.73%
Days to Cover	2.21

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Regeneron Pharmaceuticals (REGN) stock?

You can purchase shares of Regeneron Pharmaceuticals (NASDAQ:REGN) through any online brokerage.

View our list of the best stock brokerages

Who are Regeneron Pharmaceuticals (REGN) competitors?

Other companies in Regeneron Pharmaceuticals’s space includes: Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).

What is the forecast, or price target, for Regeneron Pharmaceuticals (REGN) stock?

Regeneron Pharmaceuticals has a consensus price target of $1019.07.

What is the current price for Regeneron Pharmaceuticals (REGN)?

The stock price for Regeneron Pharmaceuticals (NASDAQ: REGN) is $714.47 last updated December 24, 2024 at 1:00 PM EST.

Does Regeneron Pharmaceuticals (REGN) pay a dividend?

There are no upcoming dividends for Regeneron Pharmaceuticals.

When is Regeneron Pharmaceuticals (NASDAQ:REGN) reporting earnings?

Regeneron Pharmaceuticals’s Q4 earnings are confirmed for Friday, January 31, 2025.

Is Regeneron Pharmaceuticals (REGN) going to split?

There is no upcoming split for Regeneron Pharmaceuticals.

What sector and industry does Regeneron Pharmaceuticals (REGN) operate in?

Regeneron Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.